by Skrydalewicz Maciej | May 11, 2020
CORONA 30 Part 3 — Tuesday Topics: Telemonitoring Goal directed perfusion In the age of Coronavirus, telemonitoring and telemedicine have become household terms. How can perfusion and ECMO patients and providers use telemedicine / telemonitoring to expand advanced...
by Skrydalewicz Maciej | Apr 13, 2020
CORONA 30 ECMO Cannulation, ECMO staffing and ECMO Specialists Extracorporeal Membrane Oxygenation CORONA 30 Part 1 — Thursday Topics: ECMO Cannulation ECMO staffing and ECMO Specialists #extracorporealmembraneoxygenation #ECMO #cannulation This program will discuss...
by Skrydalewicz Maciej | Apr 2, 2020
CORONA 30 Part 1 Tuesday – Perfusion Meeting 2020 Topics: CORONA 30 Passive antibody therapy, Continuous VenoVenous Hemofiltration CVVH. Passive antibody therapy CVVH This program will discuss antibody transmission via homologous plasma transfer #perfusion #CVVH...
by Skrydalewicz Maciej | Mar 30, 2020 | ECMO, Heart Surgery
BOSTON, MASSACHUSETTS – March 15, 2020 — BIOXYTRAN, INC., (OTC: BIXT) a developmental stage biotechnology company with a pipeline of anti-necrosis drugs designed to treat hypoxia by delivering a small molecule carrying oxygen to the brain of stroke victims...
by Skrydalewicz Maciej | Mar 24, 2020
CORONA 30 Part 1 Monday – Perfusion Meeting 2020 Topics: Covid-19 – Current challenges for perfusion. Passive antibody therapy This program will explore current challenges facing perfusion in light of the Coronavirus pandemic. We will also be discussing...
